Search hospitals > Tennessee > Nashville
Vanderbilt University Medical Center
Claim this profileNashville, Tennessee 37203
Global Leader in Syndrome
Global Leader in High Blood Pressure
Conducts research for Fibrosis
Conducts research for Cancer
Conducts research for Heart Failure
1944 reported clinical trials
207 medical researchers
Summary
Vanderbilt University Medical Center is a medical facility located in Nashville, Tennessee. This center is recognized for care of Syndrome, High Blood Pressure, Fibrosis, Cancer, Heart Failure and other specialties. Vanderbilt University Medical Center is involved with conducting 1,944 clinical trials across 1,739 conditions. There are 207 research doctors associated with this hospital, such as Michael Gibson, Elizabeth J. Davis, Cyndya A Shibao, MD, and Italo Biaggioni, MD.Area of expertise
1Syndrome
Global LeaderHLA-A positive
HLA-A negative
HLA positive
2High Blood Pressure
Global LeaderCTD-ILD
6MWD
Top PIs
Michael GibsonVanderbilt University/Ingram Cancer Center4 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
17 reported clinical trials
36 drugs studied
Elizabeth J. DavisVanderbilt University/Ingram Cancer Center4 years of reported clinical research
Studies Sarcoma
Studies Tumors
16 reported clinical trials
21 drugs studied
Cyndya A Shibao, MDVanderbilt University Medical Center7 years of reported clinical research
Studies Autonomic Failure
Studies Multiple System Atrophy
15 reported clinical trials
31 drugs studied
Italo Biaggioni, MDAutonomic Dysfunction Center/ Vanderbilt University Medical Center7 years of reported clinical research
Studies Autonomic Failure
Studies Multiple System Atrophy
12 reported clinical trials
27 drugs studied
Clinical Trials running at Vanderbilt University Medical Center
Bladder Cancer
Surgical Site Infection
Parkinson's Disease
Age-Related Macular Degeneration
Infections
Osteomyelitis
Breast Cancer
High Blood Pressure
Kidney Stones
Pulmonary Arterial Hypertension
TAR-200 + Cetrelimab vs BCG
for Bladder Cancer
This trial is testing a new bladder cancer treatment using a special device to deliver a drug directly into the bladder, either alone or with an immune-boosting drug. It targets patients with high-risk bladder cancer who haven't had BCG treatment before. The device ensures a steady release of the drug, while the immune-boosting drug helps the body fight cancer.
Recruiting2 awards Phase 36 criteria
Cretostimogene Grenadenorepvec
for Bladder Cancer
This is a Phase 3, open-label, randomized trial designed to evaluate the RFS of TURBT followed by cretostimogene grenadenorepvec versus TURBT followed by observation for the treatment of participants with IR-NMIBC.
Recruiting2 awards Phase 33 criteria
CG0070
for Bladder Cancer
This is a Phase 3, open-label, single arm trial designed to evaluate Cretostimogene patients with NMIBC who have failed prior BCG therapy. Up to approximately 115 CIS bladder cancer patients with or without HG Ta or HG T1 papillary disease will be enrolled under the original protocol through Amendment 4, which will comprise Cohort C. Cohort C is closed to enrollment. Under Amendment 5-1, Cohort P was added to enroll up to 70 patients with HG Ta/T1 papillary bladder cancer. Under Amendment 6, the target number of patients enrolled in Cohort P was increased to 75. Cohort P is open to enrollment Cohort C and Cohort P will be analyzed and reported separately. Patients will have had to fail prior BCG therapy which is defined as having persistent or recurrent disease within 12 months (Cohort C) or 6 months (Cohort P) following the completion of adequate BCG therapy for HGUC
Recruiting2 awards Phase 35 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Vanderbilt University Medical Center?
Vanderbilt University Medical Center is a medical facility located in Nashville, Tennessee. This center is recognized for care of Syndrome, High Blood Pressure, Fibrosis, Cancer, Heart Failure and other specialties. Vanderbilt University Medical Center is involved with conducting 1,944 clinical trials across 1,739 conditions. There are 207 research doctors associated with this hospital, such as Michael Gibson, Elizabeth J. Davis, Cyndya A Shibao, MD, and Italo Biaggioni, MD.
Where is Vanderbilt University Medical Center located?
**Vanderbilt University Medical Center**
- **Address:** 1211 Medical Center Dr, Nashville, TN 37232
- **Parking:** Available at the Central Garage, 2120 Dixie Place, Nashville, TN 37232. Parking is free.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Vanderbilt University Medical Center, contact customer service for help with applications for community and government-sponsored programs, financial assistance policy explanations, and payment plan options. For inquiries about your Explanation of Benefits (EOB), referrals, medical claims, or bills, contact Insurance Representative Kristina Miller at Kristina.Miller@vumc.org or 615-343-4688. For insurance-related questions, use the contact form on the Office of Financial Aid website or call 615-322-3591, Monday - Friday, 8:00am - 5:00pm CST. The financial counselor at Vanderbilt Children's Hospital can assist with coverage questions, financial and insurance issues, and identify financial assistance for uninsured individuals.
What insurance does Vanderbilt University Medical Center accept?
Vanderbilt University Medical Center accepts various insurance plans, including BlueCross BlueShield, Aetna, Aetna Better Health (KY Medicaid), and Ambetter of Tennessee (Commercial), as in-network providers. However, Vanderbilt may not participate in all products offered by an insurance carrier. Specific exclusions apply, such as exclusion from Network L & E BlueCross BlueShield TennCare, and out-of-network participation in some plans like Network L. It's crucial to verify your insurance coverage and any specific exclusions or limitations at the Vanderbilt facility where you plan to receive care.
What awards or recognition has Vanderbilt University Medical Center received?
Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee, is a global leader in research, receiving over $1 billion in research funding from external organizations in 2021. This funding supports a wide range of fields including biomedical and biotechnology discoveries, vaccine development, education, and psychology. With more than 3,100 external awards totaling $1,090,386,890, VUMC's funding sources include the National Institutes of Health, the National Science Foundation, the Department of Defense, the Department of Education, and the Centers for Disease Control and Prevention.